chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Was nauseated; I had stiffness in my legs; I have mobility issues anyway; I got violently ill/I don't know that I've ever been that sick before.; I was sort of dizzy; Vomiting for 4 hrs; This spontaneous case was reported by a patient and describes the occurrence of MUSCULOSKELETAL STIFFNESS (I had stiffness in my legs), MOBILITY DECREASED (I have mobility issues anyway), ILLNESS (I got violently ill/I don't know that I've ever been that sick before.), DIZZINESS (I was sort of dizzy) and VOMITING (Vomiting for 4 hrs) in a 69-year-old patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 059F22A) for COVID-19 prophylaxis. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 25-Oct-2022 at 2:30 AM, the patient received fourth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 25-Oct-2022, the patient experienced MUSCULOSKELETAL STIFFNESS (I had stiffness in my legs). 25-Oct-2022, the patient experienced MOBILITY DECREASED (I have mobility issues anyway), ILLNESS (I got violently ill/I don't know that I've ever been that sick before.), DIZZINESS (I was sort of dizzy) and VOMITING (Vomiting for 4 hrs). On 25-Oct-2022 at 10:30 AM, the patient experienced NAUSEA (Was nauseated). At the time of the report, MUSCULOSKELETAL STIFFNESS (I had stiffness in my legs), MOBILITY DECREASED (I have mobility issues anyway), ILLNESS (I got violently ill/I don't know that I've ever been that sick before.) and DIZZINESS (I was sort of dizzy) outcome was unknown and VOMITING (Vomiting for 4 hrs) and NAUSEA (Was nauseated) had resolved.            No concomitant medications were reported.  On 14-Mar-2021, patient received first dose of Moderna Covid-19 Vaccine, batch number reported as 032M20A.  On 11-Apr-2021, patient received first dose of Moderna Covid-19 Vaccine, batch number reported as 018B21A.  On 08-Nov-2021, patient received first booster of Moderna Covid-19 Vaccine, batch number reported as 004F21A.  No treatment details were reported.
hand neuropathy; upset stomach; redness at injection site; neck pain; arm soreness / arm pain; chills; fever; This case was reported by a consumer via call center representative and described the occurrence of peripheral neuropathy in a 65-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Concurrent medical conditions included sulfonamide allergy.   On 1st April 2021, the patient received the 1st dose of Shingrix (intramuscular). In April 2021, 10 hrs after receiving Shingrix, the patient experienced peripheral neuropathy (serious criteria GSK medically significant), upset stomach, injection site erythema, neck pain, pain in arm, chills and fever. On an unknown date, the outcome of the peripheral neuropathy, upset stomach, injection site erythema, neck pain, pain in arm, chills and fever were not recovered/not resolved.   It was unknown if the reporter considered the peripheral neuropathy, upset stomach, injection site erythema, neck pain, pain in arm, chills and fever to be related to Shingrix.  Additional details were provided as follows: The patient received Shingrix on 1st April 2021 at 4 PM and about 10 hours later, the patient reports arm soreness, arm pain, redness at injection site, fever, chills, upset stomach, hand neuropathy, and neck pain.   The formulation was unknown. At time of report the events are unresolved. The reporter did not consent to follow up.
Patient began to experience fatigue, pain, and body aches the morning after his second Moderna vaccine9
Information was received from a consumer concerning her approximately 9 year old daughter with a possible sulfa allergy who in 2002 was vaccinated with a dose of HEPA. Subsequently "within minutes" the patient broke out in hives, swelling in her face, swelling at injection site and body and redness at injection site.  Unspecified medial attention was sought.  The patient recovered within six hours after receiving the vaccination.  A product quality complain was not involved.  Additional information was requsted.
This case was reported by a nurse via sales rep and described the occurrence of shivers in a 65-year-old female patient who received SHINGRIX (batch number L7F7E, expiry date unknown) for prophylaxis. On 12th June 2018, the patient received the 1st dose of SHINGRIX. In June 2018, less than a week after receiving SHINGRIX the patient experienced shivers, general body pain and upset stomach. On an unknown date, the outcome of the shivers, general body pain and upset stomach were unknown. It was unknown if the reporter considered the shivers, general body pain and upset stomach to be related to SHINGRIX.Additional information was received as follows: The patient had upset stomach, shivers, and body aches after SHINGRIX vaccination. The reporter did not agree for follow up contact. This case was linked with case US2018GSK106719, reported by the same reporter.
rash onset 17DEC95 10days p/vax small blisters draining clear fluids-itchy groin area-spreading to buttock, stomach, lower abd;8DEC95 fever 102 days following inj for 3-4 days relieved w/APAP
G40.009 FRONTAL LOBE EPILEPSY 3/29/2023 SYNCOPE AND COLLAPSE
swollen lymph nodes; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) from medical information team.  A female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection) (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported.The following information was reported: LYMPHADENOPATHY (non-serious) with onset 26Mar2021, outcome "unknown", described as "swollen lymph nodes".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Information has been received from a registered nurse via a telephone call and a physician concerning a 70 year old alert and oriented female with no known allergies and chronic rhinitis who on 11-OCT-2004 at 14:00 PM was vaccinated in her left arm with PNEUMOVAX 23. On 11-OCT-2004 at 14:00 PM, the patient was also vaccinated with the AFLURIA in her right arm. Concomitant therapy included ATARAX, ZESTORETIC and PREMARIN. On 12-OCT-2004 at 14:30, the patient reported a red, hot and swollen five inch area at her left arm injection site where she received the PNEUMOVAX 23. It was reported the five inch area at the "pneumonia vaccine" injection site was getting bigger. The patient denied pain and fever. The patient was instructed to use ice packs, take TYLENOL and call if she was not better within twenty-four hours. On 13-OCT-2004 at 8:07 AM, the patient called the registered nurse and reported she was faint and nauseous the night before. She was using ice packs and acetaminophen as recommended. On 13-OCT-2004, 08:45 AM the patient was seen by her physician. At the site of injection there was no induration and no warmth. The patient's diagnoses were left upper limb superficial cellulitis and lymphadenopathy site of injection. The patient was treated with KEFLEX for five days and was instructed to call her physician if her signs and symptoms were not improved in forty-eight hours. At the time of the report, the patient's outcome was not reported. All available medical records will be provided upon request. Additional information has been requested.
Vaccine was administered after the beyond use date. It should only be stored in the fridge for 30 days, and it had been in the fridge for 33 days when we administered it.
Experienced rapid heart rate about 2-3 hours after the first dose.  A few week after the first dose I experienced frequent, severe menstrual bleeding episodes the were not consistent with a typical period through July of 2021.  They were sporadic, yet frequent - not consistent with a monthly periods.  At the time I had IUD and had only had spotting during my cycle for nearly 7 years.   5 days after my booster in December I began having these episodes nearly daily until mid- February.  Each episode would last for a few hours and would result in the passing of clots the size of the palm of my hand and replacing 3-4 maxi pads in the 1-2 hour span. One of the worst episodes resulted in the expulsion of my IUD.  My physician performed an outpatient procedure - ablation and curettage to help control the bleeding and facilitate a return to normal function on 3/7/2022
Pt broke out w/fever blister-like lesions on lips & inside of mouth; 20APR91 developed rash around fever blister-like lesions; Seen by MD given inject & steroid pack;
This spontaneous report as received from a other health professional refers to a patient of unknown age and gender. Patient's concurrent condition, pertinent medical history, drug reactions or allergies and concomitant medications were not reported. On 09-AUG-2017 the patient was vaccinated with an expired dose of GARDASIL 9 (lot # K026246 expiry date: 28-JAN-2017) for prophylaxis (expired product administered). Dosing details and route of administration were not reported. No adverse effects were reported. No product quality complaint (PQC) was involved.
Approximately five hours after the vaccination my son was unconsolable for an hour and extremely fussy all night. He developed a rash at the injection site which then spread to his legs and torso. It took over 2 mos to clear up.
after getting the 1st dose, he was diagnosed to have Covid-19; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (after getting the 1st dose, he was diagnosed to have Covid-19) in an 83-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 (after getting the 1st dose, he was diagnosed to have Covid-19). At the time of the report, COVID-19 (after getting the 1st dose, he was diagnosed to have Covid-19) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication list was not provided. Treatment information was not provided. The patient received his 1st dose of moderna covid-19 vaccine sometime late dec-2020 or early jan-2021.   Company comment: This is a spontaneous case concerning a 83-year-old, male patient with no relevant medical condition, who experienced the unexpected non-serious AESI event of Covid-19. The event Covid-19 exact occurrence was unknown but stated that the event occurred after the first dose of mRNA-1273 vaccine administration. No reported treatment information. The outcome of the event was unknown. The patient's age, incomplete primary dose of mRNA-1273 vaccine and current Covid-19 pandemic remains confounders. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.   This case was linked to MOD-2022-506968 (Patient Link).; Sender's Comments: This is a spontaneous case concerning a 83-year-old, male patient with no relevant medical condition, who experienced the unexpected non-serious AESI event of Covid-19. The event Covid-19 exact occurrence was unknown but stated that the event occurred after the first dose of mRNA-1273 vaccine administration. No reported treatment information. The outcome of the event was unknown. The patient's age, incomplete primary dose of mRNA-1273 vaccine and current Covid-19 pandemic remains confounders. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.
After receiving the immunization, she noted redness and tenderness at  her arm as well as fatigue. Symptoms were beginning to resolve until 8/23, when she had an episode of dizziness with blurry vision while leaning on church pew, which resolved immediately when she sat back up. Tylenol OTC helps her pain. She did have 1 tablet of 400 mg Motrin however is limited in amount she can take due to history of gastric bypass.
Incomplete medical history and documentation resulted in giving immunization comprised of a dose of MMR. No adverse reaction. Immunization given at agency. 12/02/2002 Update. There is no adverse event onset date because no adverse event actually occurred. The event of the immunization (MMR) given to an 5 yr old was 05/25/2002. But, fortunately, she tolerated the immunization without contacting the measles virus. She was taking chemo Rxs at time of immunization but this wasn't communicated (language) to ER giving the MMR. The VAERS report was originally sent to you because vaccine (MMR)- containdicated for CA pts, was mis taken given to a child. Incomplete medical history and documentation resulted in giving immuno compromised due a dose of MMR- no adverse reaction- immunization given at head start agencies. No adverse reaction.
8 report incidents of adverse rxn's blurred vision; shaky feelings, 1 had neurological sx (all from this lot#);
First day - Wednesday:  Return home from work for lunch around 12am.  - leg pain (really bad, muscular-like pain. Ache, sore. Would flare. Sometimes in knees, mostly in calves... continued until midway through the night) - fatigue (felt just a little more tired than normal, really tired by bed time: 9pm) - heightened heart rate (excitement from vaccine / apprehension for potential illness?) Second day - Thursday:  - fatigue (tired all day, almost fell asleep through a couple meetings) - leg pain (reappeared in the morning, ached and throbbed. Made it difficult to relax. Was gone around 3/4pm) - headache (probably from dehydration, I was warm, but not completely a fever. Attempted to drink a lot of water, but too much made me nauseous)  - chills (sporadic, barely noticeable except it agitated the headache) - nausea (I barely ate more than a granola bar and attempted to drink water and tea, but too much made me sick, especially if it had sugar - mainly drank water. Had some soup later in the day (6pm) and most of the nausea went away)
Testicular pain that would be sharp and led to swelling. Thought it was testicular cancer or torsion potentially, but both were ruled out at visit to ER. Difficulty walking and and discomfort sitting.
Sore throat, closed throat, fever over 102 lasting for 48 hours. Patient took BENADRYL and symptoms eased up after a few minutes but sore throat and fever lasted for 48 hours.
Vaccine given 5/23/18. On 5/25/18, she had severe vomiting lasting 6 hours. She went to the ER and was told she had evevated WBC count and an unspecified infection. She was treated with KEFLEX, ZOFRAN, Pantoprazole, ZOFRAN and PERCOCET.
This spontaneous report as received from an office manager refers to an unspecified number of patients of unknown age and gender. No information regarding the patients' medical history or concurrent conditions was provided. On an unknown date in 2017, the patients were vaccinated with incorrectly stored doses of ROTATEQ oral liquid (lot# M014318, expiry date 30-SEP-2017; exact dose was not reported). There were no concomitant therapies reported. The administered doses of the vaccine were exposed to the following temperatures on the following dates: on 01-FEB-2017: 33.746 degrees Fahrenheit (F) for 23 minutes; on 03-FEB-2017: 47.336 F for 6 minutes; on 06-FEB-2017: 34.988 F for 18 minutes; on 07-FEB-2017: 34.772 F for 17 minutes; on 08-FEB-2017: 6.692 F for 1 minute and 34.592 F for 90 minutes; on 09-FEB-2017: 33.89 F for 290 minutes; on 10-FEB-2017: 32.918 F for 298 minutes; on 11-FEB-2017:33.71 F for 317 minutes; on 12-FEB-2017:34.538 F for 302 minutes; on 13-FEB-2017:34.214 F for 255 minutes; on 14-FEB-2017: 34.322 F for 333 minutes; on 15-FEB-2017: 31.108 F for 464 minutes; on 16-FEB-2017: 31.874 F for 284 minutes; on 17-FEB-2017: 31.28 F for 585 minutes; on 18-FEB-2017: 31.316 F for 512 minutes; on 19-FEB-2017: 31.55 F for 517 minutes; on 20-FEB-2017: 30.866 F for 3 minutes and 31.136 F for 566 minutes; on 21-FEB-2017: 31.406 F for 245 minutes and 48.02 F for 47 minutes; on 22-FEB-2017: -4.108 F for 1 minute; on 24-FEB-2017: 34.322 F for 180 minutes; on 25-FEB-2017: 34.106 F for 240 minutes; on 26-FEB-2017: 34.214 F for 263 minutes; on 27-FEB-2017: 34.322 F for 230 minutes; and on 28-FEB-2017: 34.394 F for 289 minutes. A digital data logger was involved. The reporter stated that there were also previous excursions on unspecified dates (details not provided). No adverse experience were reported. There was no product quality complaint involved. This is one of several reports received from the same reporter. Additional information has been requested.; Sender's Comments:  US-009507513-1703USA008835:
First instantly chest pain and a little difficulty breathing. I was like this for more than 30 min, then was relieved but Headache was added, Dizziness, sensation of nausea, neck pain, sensation of having inflamed organs, extreme tiredness, couldn't move the arm, pain all over the body, excessively dry mouth but felt the saliva very thick, several days with alternating symptoms. On the night of the vaccine the body extremely cold, nocturnal delirium.  Took Tylenol every 4 hours, the neck pain was unbearable. I was feeling bad for about 3 to 4 days.
Pt developed herpes zoster (shingle) and was seen by his MD 10/05/2005. He was seen in our office with URI 10/19/2005 and shingles essentially resolved but could be identified.
Mother phoned on 5/18/01 and stated child started "non-stop" crying on the evening of 5/17/01 at 19:00 and "acted like hurt". Not usual cry, high-pitched, did go to sleep but awoke during the night and took 1 hours to calm. No fever. Fussy Friday; awoke Saturday and was "ok". Had diarrhea and gas on Saturday, 5/19/01. On 5/22/01, had cold and cough symptoms.
2/7/07 mothers states that pt complained of arm hurting after injection. The following am patient complained arm hurting more than the day prior.  Mom looked at left arm and there was a site the size of a baseball, pink, hard and warm. No itching noted. Mom states patient eczema flared up after shot.  In talking with mom she states client has a sensitivity to eggs and allergy to soy and peanuts.  Instructed to ice site, take Tylenol or Motrin and call us if it continues more than 24 hours or gets worse. 2/8/07 much improved.
Reported symptoms include throat tightness, hives, redess around the neck, cold sweat and nausea 15 minutes after taking the vaccine
Patient who has underlying coronary artery disease, peripheral vascular disease, CHF, who came in with COVID-19 pneumonia. He was treated with remdesivir and dexamethasone, has made a good improvement and is ready for discharge. He says he is feeling good. Hospital admission within 6 weeks of receiving the COVID vaccine.
Two red circles quarter size on left back lower arm.  No itching or pain.  Still there on day 3
Mother state's client has knot to injection site, started with migraine headache, nausea, bodyaches, flu-like symptoms and diarrhea. Clients mother called on 5/24/10 stated client received tdap on 5/21/10 and developed a knot to injection site that evening. States on 5/22/10, the client woke up with a migraine headache, nausea, body aches, and flu-like symptoms. Stats today 5/24/10 client has diarrhea. Client's mother plans to call client's primary care physician to report signs and symptoms.
Client did not feel "well" 1 hour after vaccination, by 21:00 PM. Signs and symptoms included headache, backache, fever 102 F, chills, chest pain and SOB. Client went to ER at 22:30 PM. Received IV fluids and Toradol injection. Client discharged home after about 3 hours. Dx'd at ER-adverse reaction to flu vaccine.
swelling in her arm; It's very hot to touch; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (swelling in her arm) and FEELING HOT (It's very hot to touch) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, the patient experienced PERIPHERAL SWELLING (swelling in her arm) and FEELING HOT (It's very hot to touch). At the time of the report, PERIPHERAL SWELLING (swelling in her arm) and FEELING HOT (It's very hot to touch) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.  Treatment information was not provided.
Patient stated that she experienced fever, chills, fatigue nausea and vomiting after the second shot in the SHINGRIX series. ALso stated that her BP was higher than normal at 131/80.
Headache; Fever; Chills; This is a spontaneous report from a contactable consumer (patient) reported for herself. A 58-years-old female patient (patient was not pregnant at the time of vaccination) received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: EN6203, Expiration date: unknown) via an unspecified route of administration, administered in left arm on 10Mar2021 at 13:00 pm (age at vaccination was 58 years) as dose 2, single for COVID-19 immunization. The patient did not have any medical history. The patient did not have any known allergies. The patient did not receive any concomitant medications or other vaccine in two weeks. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: EL3247, Expiration date: unknown) via an unspecified route of administration, administered in left arm on 17Feb2021 at 10:00 am (age at vaccination was 58 years) as dose 1, single for COVID-19 immunization. The facility where the most recent COVID-19 vaccine was Workplace clinic. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. On 11Mar2021 at 05:00 am, the patient experienced headache, fever and chills. No treatment was received for the adverse events. The outcome of the events was resolved on an unspecified date in 2021.  No follow-up attempts are possible. No further information is expected.
Redness at injection site; Itchy at injection site; redness wide; feels like hives; This is a spontaneous report received from a contactable consumer or other non hcp. A female patient of an unspecified age received bnt162b2 (COMIRNATY,Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date as Dose number unknown,single for covid-19 immunization.The patient medical history and concomitant medications were not reported.The patient experienced redness at injection site, itchy at injection site, redness wide and feels like hives on an unspecified date.Caller notified that Pfizer is unable to provide medical advice, and Caller encouraged to contact her healthcare provider for her concern.The outcome of the event was unknown.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.